The university is 30 years old. Discover its past and present. Help build its future.
14 February 2017
Find out about bachelor's degrees, postgraduate courses and all the educational courses offered by the UdG.
Teaching is concentrated in the faculties and schools, and the departments deal with research, which is also conducted by institutes and chairs, at the same time responsible for knowledge promotion.
The group's research focuses on the field of cancer therapy and diagnosis. Two lines of research are worked on in particular:
Finding molecular markers that enable cancer to be diagnosed in its early stages, where current therapies are most effective, and which can also be used for improving tumour prognoses and follow-ups, and in the study of glycoenzymes involved in adhesion and metastasis processes, for possible treatment against their effects. Research. Heads: Dr Rosa Peracaula and Dr Esther Llop.
1.1. Tumour markers: anomalous glycosilation of various seric proteins as possible carcinoma tumour markers.
Presently focused on pancreatic and prostate carcinomas, in particular the anomalous glycosilation of over-expressed or new-expressed seric glycoproteins in pancreatic cancer and of PSAs (prostate-specific antigens). Extensible to other glycoproteins (Proteomics and Glycomics).
Molecular mechanisms responsible for changes in glycosylation in tumours
Studies of the expression of glycosyl transferases responsible for the biosynthesis of carbohydrate antigens associated with tumour, determination of their implication in different stages of tumour progression and of the factors that regulate its expression.
Development of molecules with anti-tumour activity, that go against specific targets in cancerous cells. Research. Head: Dr Anna Massaguer
2.1 epidermal growth factor (EGF) analogues as anti-tumour agents
Design and production of derivatives of family EGF growth factors (Truncated EGF and other modified ligands) with potential anti-tumour activity. Study of the resistance mechanisms to targeted therapies against EGF receptors, through the appearance of autocrine loops from the EGF/ErbB pathway.
2.2 Vehiculation of anti-tumour compounds-
Characterisation of transition-metal based complexes as potential anti-tumour agents. Study of their activity in photochemotherapy. Design and production of vehicular peptides for targeting chemotherapeutic agents to over-expressed receptors in tumours (EGF derivatives and bombesin, octreotide and RGD-peptide derivatives etc.)
Choose which types of cookies you accept which the University of Girona can store in your browser.
Those that are essential for enabling your connection. There is no option for disabling them, as they are necessary for the functioning of the website.
These enable your options to be remembered (for example language or region you are accessing from), to provide you with advanced services.
They provide statistical information and enable improved services. We use Google Analytics cookies which you can deactivate by installing this plugin.
To offer advertising contents relating to the interests of users, either directly, or through third parties (“adservers”). These must be activated if you wish to see the YouTube videos uploaded to the University of Girona’s website.
The University of Girona website uses its own and third-party cookies for technical and analytical purposes. To manage them use the manager. If you would like further information, please access our Cookies Policy.